Published in Croat Med J on June 01, 2001
Highly effective DNA extraction method for nuclear short tandem repeat testing of skeletal remains from mass graves. Croat Med J (2007) 1.18
Use of prior odds for missing persons identifications. Investig Genet (2011) 0.98
Developing role of forensics in deterring violence and genocide. Croat Med J (2007) 0.89
Depression, anxiety and somatization in women with war missing family members. Mater Sociomed (2013) 0.77
DNA fingerprinting in forensics: past, present, future. Investig Genet (2013) 0.76
Genetic examination of the putative skull of Jan Kochanowski reveals its female sex. Croat Med J (2011) 0.76
Contribution of forensic anthropology to identification process in Croatia: examples of victims recovered in wells. Croat Med J (2007) 0.75
Incidental findings in the use of DNA to identify human remains: an ethical assessment. Forensic Sci Int Genet (2012) 0.75
Income inequality, primary care, and health indicators. J Fam Pract (1999) 4.54
Mycotoxins (ochratoxin A, citrinin, and sterigmatocystin) and toxigenic fungi in grains and other agricultural products. J Agric Food Chem (1973) 3.21
Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem (1997) 3.20
Patient knowledge of anaesthesia and peri-operative care. Anaesthesia (1994) 2.61
Loss of transcriptional silencing causes sterility in old mother cells of S. cerevisiae. Cell (1996) 2.53
Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell (1996) 2.04
Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa. Nat Genet (1997) 1.84
Platelet-derived growth factor. Specific binding to target cells. J Biol Chem (1982) 1.80
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther (1999) 1.63
Contribution of exercising legs to the slow component of oxygen uptake kinetics in humans. J Appl Physiol (1985) (1991) 1.51
A prospective study of the clinical outcome of femoral pseudoaneurysms and arteriovenous fistulas induced by arterial puncture. J Vasc Surg (1993) 1.40
The central role of the prefrontal cortex in directing attention to novel events. Brain (2000) 1.39
The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. Bioorg Med Chem Lett (1999) 1.30
Chromogranin A in human hypertension. Influence of heredity. Hypertension (1995) 1.18
High muscle blood flows are not attenuated by recruitment of additional muscle mass. Am J Physiol (1995) 1.18
Analysis of dichotomous outcome data for community intervention studies. Stat Methods Med Res (2000) 1.16
Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques. AIDS Res Hum Retroviruses (1997) 1.15
Recruitment and retention of minority participants in the DASH controlled feeding trial. DASH Collaborative Research Group. Dietary Approaches to Stop Hypertension. Ethn Dis (1998) 1.11
Chronic regurgitation among persons with mental retardation: a need for combined medical and interdisciplinary strategies. Am J Ment Retard (1992) 1.01
Prospective, randomized comparison of epidural versus parenteral opioid analgesia in thoracic trauma. Ann Surg (1999) 1.00
Guns in young hands: a survey of urban teenagers' attitudes and behaviors related to handgun violence. J Trauma (1996) 0.99
Alternating lateralization of plasma catecholamines and nasal patency in humans. Life Sci (1986) 0.97
Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells. Biochem Pharmacol (1996) 0.96
Gait rehabilitation for an arm amputee. Med J Aust (1977) 0.96
A sensitive radioenzymatic assay for epinephrine forming enzymes. Life Sci (1988) 0.93
Invasive fusariosis associated with an injury by a stingray barb. J Med Vet Mycol (1990) 0.92
Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release. J Auton Pharmacol (1994) 0.92
Plasma norepinephrine kinetics, dopamine-beta-hydroxylase, and chromogranin-A, in hypothyroid patients before and following replacement therapy. J Clin Endocrinol Metab (1990) 0.91
The effects of unilateral forced nostril breathing on the heart. Int J Neurosci (1993) 0.91
Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension. Hypertension (1993) 0.91
The structure of apo protein-tyrosine phosphatase 1B C215S mutant: more than just an S --> O change. Protein Sci (2001) 0.90
Spatial quantum beats in vibrational resonant inelastic soft x-ray scattering at dissociating states in oxygen. Phys Rev Lett (2011) 0.90
Simplified procedure for the purification of ochratoxin A from extracts of Penicillium viridicatum. J Assoc Off Anal Chem (1971) 0.89
Muscle pathology of myotonia congenita. J Neurol Sci (1976) 0.88
Sources of human urinary epinephrine. Kidney Int (1997) 0.87
Students add value to learning organizations: the Medical University of South Carolina experience. Qual Manag Health Care (1998) 0.87
Anesthesia-based pain services improve the quality of postoperative pain management. Pain (1999) 0.87
Effect of chronic exercise on myocardial function. Am Heart J (1967) 0.86
Personality dysfunction in depressed adolescents. Can J Psychiatry (1989) 0.86
Ultradian variations of chromogranin A in humans. Am J Physiol (1991) 0.86
Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response. Vet Immunol Immunopathol (1998) 0.86
Sleep apnea, norepinephrine-release rate, and daytime hypertension. Sleep (1997) 0.86
Secretory non-pancreatic phospholipase A2 and cyclooxygenase-2 expression by tracheobronchial smooth muscle cells. Eur J Biochem (1996) 0.86
Mutations sensitizing yeast cells to the start inhibitor nalidixic acid. Yeast (1995) 0.86
Effects of physostigmine on pulse, blood pressure, and serum epinephrine levels. Am J Psychiatry (1985) 0.84
Evaluation of new insect growth regulators against mosquitoes with notes on nontarget organisms. J Am Mosq Control Assoc (1986) 0.83
ECHO virus type 3 infections in children: clinical and laboratory studies. J Pediatr (1972) 0.83
Comparison of efficacy of phenoxymethyl penicillin and buffered penicillin G in treatment of streptococcal pharyngitis. J Pediatr (1966) 0.83
Decreased adrenergic sensitivity in patients with hypothyroidism. J Am Coll Cardiol (1990) 0.83
Efficacy and field evaluation of Bacillus thuringiensis (H-14) and B. sphaericus against floodwater mosquitoes in California. J Am Mosq Control Assoc (1985) 0.83
Plasma epinephrine levels in hypertension and across gender and ethnicity. Life Sci (2000) 0.82
Low-frequency ultradian insulin rhythms are coupled to cardiovascular, autonomic, and neuroendocrine rhythms. Am J Physiol (1997) 0.82
Propranolol affects stress-induced leukocytosis and cellular adhesion molecule expression. Eur J Appl Physiol (2001) 0.82
ompU genes in non-toxigenic Vibrio cholerae associated with aquaculture. J Appl Microbiol (2003) 0.82
Who's in the car? Passengers as potential interveners in alcohol-involved fatal crashes. Accid Anal Prev (1995) 0.82
An Australian programme for management of back problems. Physiotherapy (1980) 0.82
Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure. Kidney Int (1990) 0.82
Patterns of adrenergic receptors and adrenergic agonists underlying cardiovascular responses to a psychological challenge. Psychosom Med (1994) 0.81
A cholinomimetic model of motion sickness and space adaptation syndrome. Aviat Space Environ Med (1984) 0.81
Peripheral blood mononuclear cell-endothelial adhesion in human hypertension following exercise. J Hypertens (2000) 0.81
Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release. Psychopharmacology (Berl) (1986) 0.81
Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics. J Med Chem (2001) 0.81
Central cholinergic stimulation causes adrenal epinephrine release. J Clin Invest (1984) 0.81
Trainee perceptions of the Family Medicine Programme. A report of a survey. Aust Fam Physician (1988) 0.80
Primary structure of protamine from the Northern pike Esox lucius. Eur J Biochem (1983) 0.80
A Delphi exercise used to identify potential causes of variation in litter size of Ontario swine. Can Vet J (1992) 0.80
Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Am J Hypertens (1990) 0.80
Rat renal epinephrine synthesis. J Clin Invest (1989) 0.80
Epinephrine synthesis in the rat iris. Invest Ophthalmol Vis Sci (1990) 0.79
Extraadrenal adrenaline formation by two separate enzymes. Experientia (1989) 0.79
Thyroid function in bulimia nervosa. Psychoneuroendocrinology (1996) 0.79
Desoxypatulinic acid from a patulin-producing strain of Penicillium patulum. Experientia (1972) 0.79
Immune function in offspring of nonhuman primates (Macaca nemestrina) exposed weekly to 1.8 g/kg ethanol during pregnancy: preliminary observations. Alcohol Clin Exp Res (1993) 0.79
Thrombotic thrombocytopenic purpura associated with statin treatment. Postgrad Med J (2004) 0.79
Sources of urinary catecholamines in renal denervated transplant recipients. J Hypertens (1990) 0.78
Does chromostatin influence catecholamine release or blood pressure in vivo? Peptides (1994) 0.78
Experimental approaches to the detection of anxiolytic activity in the rat. Ir J Med Sci (1978) 0.78
Induction of secretory phospholipase A2 confirms the systemic inflammatory nature of adjuvant arthritis. Inflammation (1998) 0.78
The Part II examination: political exercise or national standard? CMAJ (1995) 0.78
Interference between resonant and nonresonant inelastic x-ray scattering. Phys Rev Lett (2013) 0.78
The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems. Int J Clin Pharmacol Ther Toxicol (1985) 0.78
Ultradian rhythms of autonomic, cardiovascular, and neuroendocrine systems are related in humans. Am J Physiol (1996) 0.77
Socio-demographic correlates of screening intention for colorectal cancer. Aust N Z J Public Health (2000) 0.77
Effect of increased duration of high perfusion pressure on stress failure of pulmonary capillaries. Microvasc Res (1995) 0.77
Central and peripheral cholinesterase inhibition: effects on anterior pituitary and sympathomimetic function. Psychoneuroendocrinology (1986) 0.76
Epinephrine synthesis by an N-methyltransferase in rat liver. Gastroenterology (1990) 0.76
The evolving role of certified nursing assistants in long-term care facilities. Part three. Director (2000) 0.76
Cyclosporin neurotoxicity after chemotherapy. Case had features of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. BMJ (1999) 0.75
Compassion for new MDs. CMAJ (1994) 0.75
Epinephrine synthesis in rat skin by an N-methyltransferase. Arch Dermatol Res (1990) 0.75
Yes. No. Maybe. That's about as firm as the guidance gets over launching a provider-sponsored health plan. Strategy roundtable. Hosp Health Netw (1999) 0.75
Megaloblastic cytopenia in an AIDS patient treated with trimethoprim-sulfamethoxazole. N C Med J (1995) 0.75
The clinical significance of spike and wave abnormalities in the adult. Bull Los Angeles Neurol Soc (1973) 0.75
Nurse-managed cardiac clinics. Cardiovasc Nurs (1972) 0.75
Smolting in coastal cutthroat trout Onchorhynchus clarkii clarkii. J Fish Biol (2014) 0.75
The prevalence of intradermal sensitivity to various mycobacterial antigens in a group of healthy children in southeastern United States. Pediatrics (1966) 0.75
[Scabies in Rotterdam; report of 67 patients]. Ned Tijdschr Geneeskd (1972) 0.75
Pruritus ani and vulvae. West Med Med J West (1967) 0.75
Additive and synergistic interactions of monoclonal antibodies and immunotoxins reactive with breast and ovarian cancer. Immunol Ser (1994) 0.75